Freenome

Senior Information Security Analyst II

Remote

$60,000 – $90,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
InternshipJob Type
UnknownVisa
Information Security, CybersecurityIndustries

Position Overview

  • Location Type: Remote
  • Employment Type: Full-time
  • Salary: Not specified

Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. Freenome utilizes a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages. The company's mission is to drive cancer screening and save lives by building clinical, economic, and operational evidence. Their first screening test is for colorectal cancer (CRC) and advanced adenomas, with plans for further expansion. Founded in 2014, Freenome has approximately 400 employees and is growing to support its ambitious goals of providing access to better screening and earlier cancer detection. Freenome's objective is to impact patients by empowering individuals to prevent, detect, and treat their disease, fostered by a high-performing culture of respect and cross-collaboration.

About this Opportunity

The Senior Information Security Analyst is crucial in safeguarding the organization's information assets through the implementation, maintenance, and monitoring of security-related events and incidents. This role involves investigating, analyzing, and responding to cyber incidents within Freenome’s local and cloud networks or enclaves, providing expertise in evidence collection and forensic analysis. Additionally, the analyst will define and implement security controls, ensure compliance with relevant regulations and standards, and offer expertise in securing cloud and office environments. This position requires a combination of technical security skills, compliance knowledge, and a proactive approach to risk identification and mitigation.

This position reports directly to the Director of Information Security.

Responsibilities

Security Operations:

  • Implement, maintain, monitor, and improve security systems (e.g., SIEM, IDS/IPS) to detect, alert, and respond to security incidents.
  • Conduct security investigations and perform root cause analysis.
  • Ensure that incidents are correctly reported, documented, investigated, and concluded in accordance with operational policies and procedures.
  • Manage security events as part of security operations, responding to urgent alerts, which may include off-hours investigation activities.
  • Manage and maintain security infrastructure (e.g., cloud firewalls, VPNs).
  • Perform vulnerability assessments and penetration testing.

Requirements

  • Not specified

Company Information

Freenome is a high-growth biotech company dedicated to developing cancer detection tests via a standard blood draw. Their mission is to positively impact patients by enabling them to prevent, detect, and treat their diseases. The company fosters a culture characterized by respect and cross-collaboration.

Application Instructions

  • Not specified

Skills

SIEM
IDS/IPS
Vulnerability Assessments
Penetration Testing
Cloud Security
NIST
SOC 2
GDPR
Security Incident Response
Root Cause Analysis
Security Controls

Freenome

Biotechnology company for early cancer detection

About Freenome

Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations. The company's goal is to enhance cancer diagnostics and make early detection accessible to healthcare providers and patients, ultimately aiming to save lives through timely intervention.

San Francisco, CaliforniaHeadquarters
2014Year Founded
$1,032.6MTotal Funding
LATE_VCCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Competitive market-based salaries
Annual bonus opportunities
Relocation packages
Medical, dental, & vision coverage
401k
Wellness programs
Equity
PTO

Risks

Employee layoffs may affect morale and innovation efforts.
Integration of Oncimmune Ltd. could divert focus from core projects.
Competitive landscape in cancer detection may impact Freenome's market share.

Differentiation

Freenome uses a unique multiomics approach for early cancer detection.
The company focuses on non-invasive blood tests for cancer screening.
Freenome's platform designs personalized health conditions based on cell-free genome analysis.

Upsides

Recent $254 million funding boosts clinical programs and platform expansion.
Partnership with Walgreens enhances clinical trial diversity and patient recruitment.
PROACT LUNG study positions Freenome as a leader in lung cancer diagnostics.

Land your dream remote job 3x faster with AI